Our Commitment to Responsible Clinical Trial Data Sharing

As a leading science and technology company, the sharing of information related to clinical trials sponsored by our Healthcare business is central to our mission.


We are committed to developing new medicines for patients impacted by difficult-to-treat diseases as safely and quickly as possible. We believe the best way to fulfill this commitment is through clinical studies that evaluate whether our investigational products are safe and effective, which can lead to the medicine being approved and made available to the broadest number of patients possible. Once a product is approved, we continue to evaluate our marketed products by monitoring real world data and engaging in post-marketing clinical trials.

Our clinical trials follow high medical and ethical standards, in accordance with the principles laid down in the Declaration of Helsinki, and are consistent with Good Clinical Practice and applicable local laws and regulations. 

By making clinical trial information available, we are:

  • Informing patients, investigators and healthcare professionals about the clinical research we sponsor.
  • Promoting the distribution of knowledge and minimizing the risk of duplication of research efforts.
  • Supporting the publication of full manuscripts in peer-reviewed journals.
  • Contributing towards transparency and building mutual trust.

For more information: click here

Information available for researchers

Within six months after the occurrence of an approval of a new product or a new indication for an approved product in both the European Union and the United States after January 1, 2014, Merck KGaA, Darmstadt, Germany, will share study protocols, anonymized patient level, and study level data and redacted clinical study reports from clinical trials in patients with qualified scientific and medical researchers, upon researcher's request, as necessary for conducting legitimate research. If approval of a product is not sought, Merck KGaA, Darmstadt, Germany shall make publicly available such data within eighteen months after the trial completion date. Data will not be shared for products and indications approved prior to January 1, 2014. Clinical Trials in scope of our Responsible Data Sharing Commitment are listed on our clinical trials website. In addition, data will not be shared with our competitors. Learn more about requesting information with the Summary of our Responsible Data Sharing Policy for Researchers.

Interested Researchers?

If you are an appropriately qualified researcher, please see below for more information on how to request data from Merck KGaA, Darmstadt, Germany.

Please note the following: The Data Sharing Agreement found here is a template. We suggest that you review the terms and conditions of our standard Data Sharing Agreement with the appropriate legal and/or contract personnel at your institution before submitting your Research Proposal. The terms of the Data Sharing Agreement are not negotiable. All information must be submitted in English.

Step 1: Requesting Data

Step 1: Requesting Data

Step 2: Research Evaluation

Step 2: Research Evaluation

Step 3: Accessing Data

Step 3: Accessing Data

Learn more about our standards for conducting clinical trials around the world under Positions & Policies

US/NPR/0517/0230(1)a(1)c(1)

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement